rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Cynthia Sirard

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Compass Therapeutics; Chief Medical Officer, Cypherpunk Technologies.

In numbers

Trades disclosed
17
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
0
First trade
9 Apr 2020
Last trade
2 Jan 2026
Last filed
5 Jan 2026

Companies traded

Where they are an officer
CMPX Compass TherapeuticsOfficer · Biotechnology · last 2 Jan 20260 buys · 0 sells
CYPH Cypherpunk TechnologiesOfficer, 10% owner · Biotechnology · last 28 Mar 20250 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 5 Jan 2026CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,000,000 at $0.00filing
2 Jan 2026filed 5 Jan 2026CMPX Compass Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—1,000,000 at $0.00filing
28 Mar 2025filed 1 Apr 2025CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code M—22,500 at $0.00filing
28 Mar 2025filed 1 Apr 2025CYPH Cypherpunk TechnologiesBiotechnologySEC FORM 4 Code M—22,500filing
2 Oct 2024filed 4 Oct 2024CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—85,000 at $0.00filing
29 Jan 2024filed 31 Jan 2024CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—85,000 at $0.00filing
26 Jan 2024filed 30 Jan 2024CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
26 Jan 2024filed 30 Jan 2024CYPH Cypherpunk TechnologiesBiotechnologySEC FORM 4 Code M—5,000filing
23 Aug 2023filed 25 Aug 2023CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—70,000 at $0.00filing
31 Mar 2023filed 4 Apr 2023CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—500,000 at $0.00filing
1 Sep 2022filed 2 Sep 2022CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
31 Jan 2022filed 2 Feb 2022CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—225,000 at $0.00filing
26 May 2021filed 28 May 2021CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
26 Jan 2021filed 28 Jan 2021CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
26 Jan 2021filed 28 Jan 2021CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
10 Aug 2020filed 12 Aug 2020CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—75,000 at $0.00filing
9 Apr 2020filed 13 Apr 2020CYPH Cypherpunk Technologiesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Winklevoss Capital Fund, LLC10% owner · 10% owner at Cypherpunk Technologies, filing Form 4 there in the last year
William Patrick McEvoy IIIChief Investment Officer · Chief Investment Officer at Cypherpunk Technologies, filing Form 4 there in the last year
Neil LernerChief Accounting Officer · Chief Accounting Officer at Compass Therapeutics, filing Form 4 there in the last year
Patricia A. MartinDirector · Director at Cypherpunk Technologies, filing Form 4 there in the last year
Khing Djien OeiDirector · Director at Cypherpunk Technologies, filing Form 4 there in the last year